biological regulation (GO:0065007) | 0.39 | 13 | SCN2B, SCN5A, KCNA5, KCNQ1, SCN3B, GJA5, KCNJ2, NUP155, KCNE2, NPPA, ABCC9, SCN4B, SCN1B |
regulation of biological process (GO:0050789) | 0.45 | 13 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, NUP155, KCNE2, NPPA, ABCC9, SCN4B, SCN1B |
single-organism process (GO:0044699) | 0.48 | 13 | SCN2B, SCN5A, KCNA5, KCNQ1, SCN3B, GJA5, KCNJ2, NUP155, KCNE2, NPPA, ABCC9, SCN4B, SCN1B |
regulation of membrane potential (GO:0042391) | 3.89 | 12 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, NUP155, KCNE2, NPPA, SCN4B, SCN1B |
cellular process (GO:0009987) | 0.26 | 12 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNJ2, NUP155, KCNE2, NPPA, ABCC9, KCNA5, SCN1B |
regulation of biological quality (GO:0065008) | 1.68 | 12 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, NUP155, KCNE2, NPPA, SCN4B, SCN1B |
regulation of system process (GO:0044057) | 3.53 | 12 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, KCNE2, NPPA, ABCC9, SCN4B, SCN1B |
regulation of transport (GO:0051049) | 2.24 | 12 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNJ2, NUP155, KCNE2, NPPA, KCNA5, SCN4B, SCN1B |
transport (GO:0006810) | 1.51 | 12 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, NUP155, KCNE2, ABCC9, SCN4B, SCN1B |
regulation of cellular process (GO:0050794) | 0.5 | 12 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNJ2, NUP155, KCNE2, NPPA, ABCC9, KCNA5, SCN1B |
regulation of heart contraction (GO:0008016) | 4.35 | 12 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNJ2, KCNE2, NPPA, ABCC9, KCNA5, SCN4B, SCN1B |
single-organism cellular process (GO:0044763) | 0.65 | 12 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNJ2, NUP155, KCNE2, NPPA, ABCC9, KCNA5, SCN1B |
regulation of multicellular organismal process (GO:0051239) | 1.87 | 12 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, KCNE2, NPPA, ABCC9, SCN4B, SCN1B |
regulation of blood circulation (GO:1903522) | 4.05 | 12 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, KCNE2, NPPA, ABCC9, SCN4B, SCN1B |
regulation of localization (GO:0032879) | 1.94 | 12 | SCN2B, SCN5A, SCN4B, KCNQ1, SCN3B, GJA5, KCNJ2, NUP155, KCNE2, NPPA, KCNA5, SCN1B |
establishment of localization (GO:0051234) | 1.48 | 12 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNJ2, NUP155, KCNE2, ABCC9, KCNA5, SCN4B, SCN1B |
localization (GO:0051179) | 1.4 | 12 | SCN2B, SCN5A, SCN4B, KCNQ1, SCN3B, GJA5, KCNJ2, NUP155, KCNE2, ABCC9, KCNA5, SCN1B |
multicellular organismal process (GO:0032501) | 1.45 | 11 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, KCNE2, NPPA, SCN4B, SCN1B |
cardiac muscle cell action potential (GO:0086001) | 6.33 | 11 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, NUP155, KCNE2, SCN4B, SCN1B |
cardiac muscle cell action potential involved in contraction (GO:0086002) | 6.47 | 11 | SCN2B, SCN5A, SCN4B, KCNQ1, SCN3B, GJA5, KCNJ2, NUP155, KCNE2, KCNA5, SCN1B |
cation transport (GO:0006812) | 3.11 | 11 | SCN2B, SCN5A, KCNA5, KCNQ1, SCN3B, GJA5, KCNJ2, KCNE2, ABCC9, SCN4B, SCN1B |
ion transport (GO:0006811) | 2.66 | 11 | SCN2B, SCN5A, SCN4B, KCNQ1, SCN3B, GJA5, KCNJ2, KCNE2, ABCC9, KCNA5, SCN1B |
transmembrane transport (GO:0055085) | 2.72 | 11 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, KCNE2, ABCC9, SCN4B, SCN1B |
regulation of heart rate (GO:0002027) | 5.29 | 11 | SCN2B, SCN5A, KCNA5, KCNQ1, SCN3B, GJA5, KCNJ2, KCNE2, NPPA, SCN4B, SCN1B |
metal ion transport (GO:0030001) | 3.36 | 11 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNJ2, KCNE2, ABCC9, KCNA5, SCN4B, SCN1B |
regulation of transmembrane transport (GO:0034762) | 3.74 | 11 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNJ2, KCNE2, NPPA, KCNA5, SCN4B, SCN1B |
action potential (GO:0001508) | 5.42 | 11 | SCN2B, SCN5A, KCNA5, KCNQ1, SCN3B, GJA5, KCNJ2, NUP155, KCNE2, SCN4B, SCN1B |
regulation of ion transmembrane transport (GO:0034765) | 3.77 | 11 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, KCNE2, NPPA, SCN4B, SCN1B |
monovalent inorganic cation transport (GO:0015672) | 3.74 | 11 | SCN2B, SCN5A, KCNA5, KCNQ1, SCN3B, GJA5, KCNJ2, KCNE2, ABCC9, SCN4B, SCN1B |
regulation of ion transport (GO:0043269) | 3.4 | 11 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, KCNE2, NPPA, SCN4B, SCN1B |
single organism signaling (GO:0044700) | 3.25 | 10 | SCN2B, SCN5A, SCN4B, KCNQ1, SCN3B, GJA5, KCNJ2, KCNE2, KCNA5, SCN1B |
cardiac conduction (GO:0061337) | 5.54 | 10 | SCN2B, SCN5A, SCN4B, KCNQ1, SCN3B, GJA5, KCNJ2, KCNE2, KCNA5, SCN1B |
single-multicellular organism process (GO:0044707) | 1.78 | 10 | SCN2B, SCN5A, SCN4B, KCNQ1, SCN3B, GJA5, KCNJ2, KCNE2, KCNA5, SCN1B |
regulation of metal ion transport (GO:0010959) | 3.94 | 10 | SCN2B, SCN5A, KCNQ1, KCNE2, KCNJ2, SCN3B, NPPA, KCNA5, SCN4B, SCN1B |
ion transmembrane transport (GO:0034220) | 3.08 | 10 | SCN2B, SCN4B, KCNQ1, KCNE2, KCNA5, KCNJ2, SCN3B, ABCC9, SCN5A, SCN1B |
regulation of heart rate by cardiac conduction (GO:0086091) | 6.33 | 10 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNJ2, KCNE2, KCNA5, SCN4B, SCN1B |
signaling (GO:0023052) | 3.25 | 10 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, KCNE2, SCN4B, SCN1B |
inorganic cation transmembrane transport (GO:0098662) | 3.55 | 10 | SCN2B, SCN4B, KCNQ1, KCNE2, KCNA5, KCNJ2, SCN3B, ABCC9, SCN5A, SCN1B |
inorganic ion transmembrane transport (GO:0098660) | 3.38 | 10 | SCN2B, SCN5A, SCN4B, KCNQ1, KCNE2, KCNJ2, SCN3B, ABCC9, KCNA5, SCN1B |
positive regulation of biological process (GO:0048518) | 1.2 | 10 | SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, KCNE2, NPPA, SCN4B, SCN1B |
cation transmembrane transport (GO:0098655) | 3.43 | 10 | SCN2B, SCN5A, KCNQ1, KCNE2, KCNJ2, SCN3B, ABCC9, KCNA5, SCN4B, SCN1B |
multicellular organismal signaling (GO:0035637) | 5.36 | 10 | SCN2B, SCN5A, KCNQ1, SCN3B, GJA5, KCNA5, KCNJ2, KCNE2, SCN4B, SCN1B |
system process (GO:0003008) | 2.3 | 10 | SCN2B, SCN5A, KCNQ1, GJA5, KCNJ2, SCN3B, NPPA, KCNA5, SCN4B, SCN1B |
response to stimulus (GO:0050896) | 1.22 | 9 | SCN2B, KCNA5, KCNQ1, KCNE2, KCNJ2, NPPA, ABCC9, SCN5A, SCN1B |
regulation of cation transmembrane transport (GO:1904062) | 4.4 | 9 | SCN2B, SCN5A, KCNQ1, KCNE2, KCNJ2, SCN3B, NPPA, SCN4B, SCN1B |
regulation of membrane repolarization (GO:0060306) | 6.4 | 9 | SCN5A, SCN4B, KCNQ1, GJA5, KCNJ2, KCNE2, NPPA, KCNA5, SCN1B |
positive regulation of ion transport (GO:0043270) | 4.36 | 8 | SCN4B, KCNQ1, KCNE2, KCNJ2, SCN3B, NPPA, SCN5A, SCN1B |
muscle system process (GO:0003012) | 4.18 | 8 | SCN2B, SCN4B, KCNQ1, SCN3B, KCNJ2, NPPA, SCN5A, SCN1B |
positive regulation of transport (GO:0051050) | 2.9 | 8 | SCN4B, KCNQ1, KCNE2, KCNJ2, SCN3B, NPPA, SCN5A, SCN1B |
regulation of cardiac muscle cell membrane repolarization (GO:0099623) | 6.68 | 8 | SCN5A, SCN4B, KCNQ1, GJA5, KCNE2, NPPA, KCNA5, SCN1B |
positive regulation of cellular process (GO:0048522) | 1.3 | 8 | SCN5A, KCNQ1, GJA5, KCNJ2, KCNE2, NPPA, KCNA5, SCN1B |
developmental process (GO:0032502) | 1.36 | 7 | SCN2B, SCN5A, KCNQ1, SCN3B, KCNE2, GJA5, NPPA |
regulation of ion transmembrane transporter activity (GO:0032412) | 4.55 | 7 | SCN2B, SCN4B, KCNQ1, SCN3B, KCNE2, NPPA, SCN1B |
regulation of transmembrane transporter activity (GO:0022898) | 4.52 | 7 | SCN2B, SCN4B, KCNQ1, SCN3B, KCNE2, NPPA, SCN1B |
regulation of transporter activity (GO:0032409) | 4.45 | 7 | SCN2B, SCN4B, KCNQ1, SCN3B, KCNE2, NPPA, SCN1B |
response to chemical (GO:0042221) | 1.98 | 7 | SCN2B, SCN5A, KCNQ1, KCNE2, NPPA, KCNA5, SCN1B |
regulation of molecular function (GO:0065009) | 1.78 | 7 | SCN2B, SCN4B, KCNQ1, SCN3B, KCNE2, NPPA, SCN1B |
single-organism localization (GO:1902578) | 2.09 | 7 | KCNA5, KCNQ1, KCNE2, KCNJ2, NUP155, SCN3B, ABCC9 |
muscle contraction (GO:0006936) | 4.37 | 6 | SCN2B, SCN4B, KCNQ1, SCN3B, SCN5A, SCN1B |
potassium ion transport (GO:0006813) | 4.68 | 6 | KCNA5, KCNQ1, GJA5, KCNJ2, KCNE2, ABCC9 |
positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 6 | SCN5A, KCNQ1, SCN3B, GJA5, NPPA, SCN1B |
anatomical structure development (GO:0048856) | 1.58 | 6 | SCN2B, SCN5A, KCNQ1, SCN3B, KCNE2, GJA5 |
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 6.84 | 6 | SCN5A, KCNQ1, GJA5, KCNE2, SCN4B, SCN1B |
membrane depolarization (GO:0051899) | 5.62 | 6 | SCN2B, SCN5A, SCN3B, KCNJ2, SCN4B, SCN1B |
striated muscle contraction (GO:0006941) | 5.37 | 6 | SCN2B, SCN4B, KCNQ1, SCN3B, SCN5A, SCN1B |
single-organism transport (GO:0044765) | 2.18 | 6 | KCNA5, KCNQ1, KCNE2, KCNJ2, NUP155, ABCC9 |
membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 7.09 | 6 | SCN2B, SCN4B, SCN3B, KCNJ2, SCN5A, SCN1B |
negative regulation of biological process (GO:0048519) | 1.33 | 6 | KCNA5, KCNQ1, GJA5, NUP155, KCNE2, NPPA |
membrane depolarization during action potential (GO:0086010) | 6.07 | 6 | SCN2B, SCN4B, SCN3B, KCNJ2, SCN5A, SCN1B |
cardiac muscle contraction (GO:0060048) | 5.88 | 6 | SCN2B, SCN5A, KCNQ1, SCN3B, SCN4B, SCN1B |
regulation of homeostatic process (GO:0032844) | 3.65 | 5 | SCN2B, SCN3B, SCN5A, GJA5, SCN1B |
regulation of potassium ion transport (GO:0043266) | 5.31 | 5 | KCNJ2, KCNQ1, KCNA5, NPPA, KCNE2 |
regulation of striated muscle contraction (GO:0006942) | 5.38 | 5 | KCNJ2, KCNQ1, SCN5A, NPPA, GJA5 |
regulation of signaling (GO:0023051) | 1.72 | 5 | ABCC9, GJA5, KCNA5, NPPA, KCNE2 |
cellular component organization or biogenesis (GO:0071840) | 1.22 | 5 | KCNJ2, NUP155, KCNA5, GJA5, SCN3B |
ventricular cardiac muscle cell action potential (GO:0086005) | 7.02 | 5 | KCNQ1, SCN3B, SCN5A, GJA5, KCNE2 |
cellular response to stimulus (GO:0051716) | 1.97 | 5 | KCNJ2, KCNQ1, SCN5A, NPPA, KCNE2 |
cellular potassium ion transport (GO:0071804) | 4.79 | 5 | KCNJ2, ABCC9, KCNA5, KCNE2, KCNQ1 |
potassium ion transmembrane transport (GO:0071805) | 4.79 | 5 | KCNJ2, ABCC9, KCNA5, KCNE2, KCNQ1 |
cellular component organization (GO:0016043) | 1.24 | 5 | KCNJ2, NUP155, KCNA5, SCN3B, GJA5 |
sodium ion transmembrane transport (GO:0035725) | 5.23 | 5 | SCN2B, SCN5A, SCN4B, SCN3B, SCN1B |
regulation of sodium ion transport (GO:0002028) | 5.4 | 5 | SCN2B, SCN5A, SCN4B, SCN3B, SCN1B |
regulation of sodium ion transmembrane transport (GO:1902305) | 5.86 | 5 | SCN2B, SCN5A, SCN4B, SCN3B, SCN1B |
regulation of muscle contraction (GO:0006937) | 4.75 | 5 | KCNJ2, KCNQ1, SCN5A, GJA5, NPPA |
sodium ion transport (GO:0006814) | 4.75 | 5 | SCN2B, SCN5A, SCN4B, SCN3B, SCN1B |
single-organism developmental process (GO:0044767) | 1.49 | 5 | KCNQ1, GJA5, SCN5A, NPPA, KCNE2 |
positive regulation of blood circulation (GO:1903524) | 5.16 | 5 | KCNQ1, SCN3B, SCN5A, GJA5, NPPA |
regulation of muscle system process (GO:0090257) | 4.51 | 5 | KCNJ2, KCNQ1, SCN5A, GJA5, NPPA |
regulation of postsynaptic membrane potential (GO:0060078) | 5.72 | 5 | SCN2B, SCN5A, SCN4B, SCN3B, SCN1B |
regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 7.65 | 5 | SCN2B, SCN3B, SCN5A, GJA5, SCN1B |
regulation of cardiac muscle contraction (GO:0055117) | 5.57 | 5 | KCNJ2, KCNQ1, SCN5A, GJA5, NPPA |
regulation of membrane depolarization (GO:0003254) | 6.04 | 5 | SCN2B, SCN3B, SCN5A, GJA5, SCN1B |
regulation of ion homeostasis (GO:2000021) | 4.44 | 5 | SCN2B, SCN3B, SCN5A, GJA5, SCN1B |
atrial cardiac muscle cell action potential (GO:0086014) | 7.65 | 4 | KCNQ1, NUP155, KCNA5, SCN3B |
response to external stimulus (GO:0009605) | 2.55 | 4 | KCNJ2, ABCC9, KCNA5, NPPA |
cell communication (GO:0007154) | 3.04 | 4 | SCN2B, SCN5A, GJA5, SCN1B |
positive regulation of cation transmembrane transport (GO:1904064) | 5.17 | 4 | KCNJ2, KCNQ1, NPPA, KCNE2 |
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372) | 7.94 | 4 | KCNQ1, SCN5A, KCNA5, NPPA |
membrane repolarization (GO:0086009) | 7.02 | 4 | KCNJ2, KCNQ1, KCNA5, KCNE2 |
regulation of potassium ion transmembrane transport (GO:1901379) | 5.62 | 4 | KCNJ2, KCNQ1, NPPA, KCNE2 |
membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 7.43 | 4 | KCNJ2, KCNQ1, KCNA5, KCNE2 |
cardiac muscle cell membrane repolarization (GO:0099622) | 7.43 | 4 | KCNJ2, KCNQ1, KCNA5, KCNE2 |
positive regulation of heart contraction (GO:0045823) | 6.15 | 4 | KCNQ1, SCN5A, NPPA, SCN3B |
positive regulation of heart rate (GO:0010460) | 6.59 | 4 | SCN5A, KCNQ1, NPPA, SCN3B |
regulation of sodium ion transmembrane transporter activity (GO:2000649) | 6.09 | 4 | SCN2B, SCN4B, SCN3B, SCN1B |
positive regulation of transmembrane transport (GO:0034764) | 4.99 | 4 | KCNJ2, KCNQ1, NPPA, KCNE2 |
system development (GO:0048731) | 2.92 | 4 | SCN2B, KCNQ1, SCN3B, GJA5 |
membrane repolarization during action potential (GO:0086011) | 7.43 | 4 | KCNJ2, KCNQ1, KCNA5, KCNE2 |
positive regulation of ion transmembrane transport (GO:0034767) | 5.05 | 4 | KCNJ2, KCNQ1, NPPA, KCNE2 |
positive regulation of sodium ion transport (GO:0010765) | 6.23 | 4 | SCN5A, SCN4B, SCN3B, SCN1B |
cellular component assembly (GO:0022607) | 2.14 | 3 | KCNJ2, KCNA5, GJA5 |
regulation of secretion (GO:0051046) | 3.2 | 3 | KCNQ1, KCNA5, GJA5 |
macromolecular complex subunit organization (GO:0043933) | 2.14 | 3 | KCNJ2, KCNA5, GJA5 |
regulation of cardiac conduction (GO:1903779) | 5.57 | 3 | ABCC9, GJA5, NPPA |
regulation of response to stimulus (GO:0048583) | 1.54 | 3 | NUP155, KCNQ1, KCNE2 |
negative regulation of potassium ion transport (GO:0043267) | 6.26 | 3 | KCNQ1, KCNA5, KCNE2 |
cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 3 | NUP155, KCNQ1, NPPA |
circulatory system process (GO:0003013) | 4.38 | 3 | KCNA5, NPPA, GJA5 |
signal transduction (GO:0007165) | 1.28 | 3 | ABCC9, KCNA5, NPPA |
cellular response to chemical stimulus (GO:0070887) | 2.57 | 3 | KCNQ1, SCN5A, KCNE2 |
vascular process in circulatory system (GO:0003018) | 4.65 | 3 | KCNA5, NPPA, GJA5 |
potassium ion import (GO:0010107) | 6.4 | 3 | KCNJ2, ABCC9, KCNE2 |
regulation of cell communication (GO:0010646) | 1.73 | 3 | KCNA5, GJA5, KCNE2 |
organic cyclic compound metabolic process (GO:1901360) | 1.26 | 3 | NUP155, KCNQ1, NPPA |
positive regulation of potassium ion transport (GO:0043268) | 6.09 | 3 | KCNJ2, KCNQ1, NPPA |
regulation of cardiac muscle cell contraction (GO:0086004) | 6.51 | 3 | KCNJ2, SCN5A, GJA5 |
nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 3 | NUP155, KCNQ1, NPPA |
potassium ion export (GO:0071435) | 7.43 | 3 | KCNQ1, KCNA5, KCNE2 |
regulation of blood vessel size (GO:0050880) | 4.8 | 3 | KCNA5, NPPA, GJA5 |
regulation of metabolic process (GO:0019222) | 1.02 | 3 | NUP155, KCNQ1, KCNE2 |
protein complex subunit organization (GO:0071822) | 2.6 | 3 | KCNJ2, KCNA5, GJA5 |
response to mechanical stimulus (GO:0009612) | 4.41 | 3 | KCNJ2, KCNA5, NPPA |
regulation of anatomical structure size (GO:0090066) | 3.78 | 3 | KCNA5, NPPA, GJA5 |
macromolecular complex assembly (GO:0065003) | 2.55 | 3 | KCNJ2, KCNA5, GJA5 |
organic substance metabolic process (GO:0071704) | 0.63 | 3 | NUP155, KCNQ1, NPPA |
regulation of action potential (GO:0098900) | 6.07 | 3 | KCNJ2, SCN5A, GJA5 |
heterocycle metabolic process (GO:0046483) | 1.31 | 3 | NUP155, KCNQ1, NPPA |
positive regulation of potassium ion transmembrane transport (GO:1901381) | 6.43 | 3 | KCNJ2, KCNQ1, NPPA |
regulation of tube size (GO:0035150) | 4.79 | 3 | KCNA5, NPPA, GJA5 |
protein oligomerization (GO:0051259) | 3.71 | 3 | KCNJ2, KCNA5, GJA5 |
regulation of actin filament-based process (GO:0032970) | 3.97 | 3 | KCNJ2, SCN5A, GJA5 |
regulation of actin filament-based movement (GO:1903115) | 6.33 | 3 | KCNJ2, SCN5A, GJA5 |
primary metabolic process (GO:0044238) | 0.69 | 3 | NUP155, KCNQ1, NPPA |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 3 | NUP155, KCNQ1, KCNE2 |
neurological system process (GO:0050877) | 2.64 | 3 | KCNQ1, SCN3B, SCN1B |
protein complex assembly (GO:0006461) | 2.78 | 3 | KCNJ2, KCNA5, GJA5 |
cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 3 | NUP155, KCNQ1, NPPA |
regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373) | 7.78 | 3 | SCN5A, SCN3B, GJA5 |
negative regulation of ion transport (GO:0043271) | 4.94 | 3 | KCNQ1, KCNA5, KCNE2 |
response to stress (GO:0006950) | 1.8 | 3 | ABCC9, KCNA5, NPPA |
metabolic process (GO:0008152) | 0.58 | 3 | NUP155, KCNQ1, NPPA |
response to organic substance (GO:0010033) | 2.2 | 3 | KCNQ1, KCNA5, NPPA |
SA node cell action potential (GO:0086015) | 7.94 | 3 | SCN5A, SCN3B, GJA5 |
multi-organism process (GO:0051704) | 2.65 | 3 | ABCC9, NUP155, NPPA |
response to oxygen-containing compound (GO:1901700) | 2.57 | 3 | KCNQ1, KCNA5, NPPA |
response to abiotic stimulus (GO:0009628) | 2.8 | 3 | KCNJ2, KCNA5, NPPA |
regulation of cellular component movement (GO:0051270) | 3.08 | 3 | KCNJ2, SCN5A, GJA5 |
regulation of potassium ion transmembrane transporter activity (GO:1901016) | 6.02 | 3 | KCNQ1, NPPA, KCNE2 |
cellular metabolic process (GO:0044237) | 0.69 | 3 | NUP155, KCNQ1, NPPA |
negative regulation of transport (GO:0051051) | 3.6 | 3 | KCNQ1, KCNA5, KCNE2 |
nitrogen compound metabolic process (GO:0006807) | 1.13 | 3 | NUP155, KCNQ1, NPPA |
regulation of delayed rectifier potassium channel activity (GO:1902259) | 6.84 | 3 | KCNQ1, NPPA, KCNE2 |
regulation of cation channel activity (GO:2001257) | 5.27 | 3 | KCNQ1, NPPA, KCNE2 |
negative regulation of cellular process (GO:0048523) | 1.41 | 3 | KCNQ1, NPPA, KCNE2 |
protein localization (GO:0008104) | 2.36 | 2 | NUP155, SCN3B |
response to toxic substance (GO:0009636) | 4.88 | 2 | SCN2B, SCN1B |
regulation of vasoconstriction (GO:0019229) | 5.51 | 2 | KCNA5, GJA5 |
membrane organization (GO:0061024) | 3.04 | 2 | NUP155, SCN3B |
potassium ion homeostasis (GO:0055075) | 6.84 | 2 | KCNJ2, KCNA5 |
positive regulation of striated muscle contraction (GO:0045989) | 6.96 | 2 | KCNQ1, NPPA |
cell surface receptor signaling pathway (GO:0007166) | 2.09 | 2 | KCNA5, NPPA |
membrane depolarization during Purkinje myocyte cell action potential (GO:0086047) | 9.04 | 2 | SCN5A, SCN1B |
inorganic ion homeostasis (GO:0098771) | 3.43 | 2 | KCNJ2, KCNA5 |
negative regulation of ion transmembrane transport (GO:0034766) | 5.47 | 2 | KCNQ1, KCNE2 |
organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 2 | NUP155, NPPA |
negative regulation of transmembrane transport (GO:0034763) | 5.38 | 2 | KCNQ1, KCNE2 |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 2 | NUP155, KCNQ1 |
cellular macromolecule localization (GO:0070727) | 3.1 | 2 | NUP155, SCN3B |
interspecies interaction between organisms (GO:0044419) | 3.08 | 2 | ABCC9, NUP155 |
gene silencing (GO:0016458) | 4.6 | 2 | NUP155, KCNQ1 |
animal organ development (GO:0048513) | 2.53 | 2 | GJA5, KCNE2 |
positive regulation of molecular function (GO:0044093) | 2.23 | 2 | NPPA, KCNE2 |
negative regulation of molecular function (GO:0044092) | 2.74 | 2 | KCNQ1, KCNE2 |
macromolecule localization (GO:0033036) | 2.34 | 2 | NUP155, SCN3B |
regulation of cell proliferation (GO:0042127) | 2.41 | 2 | SCN5A, KCNA5 |
sensory perception (GO:0007600) | 2.93 | 2 | KCNQ1, SCN3B |
protein localization to membrane (GO:0072657) | 3.95 | 2 | NUP155, SCN3B |
negative regulation of voltage-gated potassium channel activity (GO:1903817) | 7.53 | 2 | KCNQ1, KCNE2 |
response to inorganic substance (GO:0010035) | 3.56 | 2 | SCN5A, KCNA5 |
protein metabolic process (GO:0019538) | 1.45 | 2 | NUP155, NPPA |
response to organonitrogen compound (GO:0010243) | 3.2 | 2 | KCNQ1, NPPA |
chemical homeostasis (GO:0048878) | 2.97 | 2 | KCNJ2, KCNA5 |
membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915) | 8.34 | 2 | KCNQ1, KCNE2 |
anterograde trans-synaptic signaling (GO:0098916) | 3.98 | 2 | SCN2B, SCN1B |
renal system process (GO:0003014) | 5.17 | 2 | KCNQ1, GJA5 |
positive regulation of ion transmembrane transporter activity (GO:0032414) | 5.55 | 2 | NPPA, KCNE2 |
negative regulation of metabolic process (GO:0009892) | 1.93 | 2 | NUP155, KCNQ1 |
positive regulation of transporter activity (GO:0032411) | 5.44 | 2 | NPPA, KCNE2 |
negative regulation of ion transmembrane transporter activity (GO:0032413) | 5.74 | 2 | KCNQ1, KCNE2 |
cellular response to mechanical stimulus (GO:0071260) | 5.33 | 2 | KCNJ2, NPPA |
negative regulation of gene expression (GO:0010629) | 2.48 | 2 | NUP155, KCNQ1 |
regulation of protein transport (GO:0051223) | 3.12 | 2 | KCNA5, GJA5 |
cellular protein metabolic process (GO:0044267) | 1.63 | 2 | NUP155, NPPA |
response to hypoxia (GO:0001666) | 4.13 | 2 | KCNA5, NPPA |
regulation of protein secretion (GO:0050708) | 3.77 | 2 | KCNA5, GJA5 |
cellular macromolecule metabolic process (GO:0044260) | 0.93 | 2 | NUP155, NPPA |
cellular response to abiotic stimulus (GO:0071214) | 4.15 | 2 | KCNJ2, NPPA |
heterocycle biosynthetic process (GO:0018130) | 1.7 | 2 | NUP155, NPPA |
regulation of establishment of protein localization (GO:0070201) | 3.02 | 2 | KCNA5, GJA5 |
single-organism membrane organization (GO:0044802) | 3.19 | 2 | NUP155, SCN3B |
aromatic compound biosynthetic process (GO:0019438) | 1.7 | 2 | NUP155, NPPA |
nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 2 | NUP155, NPPA |
RNA metabolic process (GO:0016070) | 1.59 | 2 | NUP155, NPPA |
cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 2 | NUP155, NPPA |
response to decreased oxygen levels (GO:0036293) | 4.09 | 2 | KCNA5, NPPA |
regulation of response to stress (GO:0080134) | 2.53 | 2 | NUP155, KCNQ1 |
macromolecule biosynthetic process (GO:0009059) | 1.61 | 2 | NUP155, NPPA |
ventricular cardiac muscle cell membrane repolarization (GO:0099625) | 8.34 | 2 | KCNQ1, KCNE2 |
negative regulation of cation channel activity (GO:2001258) | 6.26 | 2 | KCNQ1, KCNE2 |
response to insecticide (GO:0017085) | 7.33 | 2 | SCN2B, SCN1B |
synaptic signaling (GO:0099536) | 3.98 | 2 | SCN2B, SCN1B |
trans-synaptic signaling (GO:0099537) | 3.98 | 2 | SCN2B, SCN1B |
RNA biosynthetic process (GO:0032774) | 1.84 | 2 | NUP155, NPPA |
ion homeostasis (GO:0050801) | 3.42 | 2 | KCNJ2, KCNA5 |
chemical synaptic transmission (GO:0007268) | 3.98 | 2 | SCN2B, SCN1B |
regulation of cellular component organization (GO:0051128) | 2.01 | 2 | NPPA, SCN1B |
cellular biosynthetic process (GO:0044249) | 1.37 | 2 | NUP155, NPPA |
regulation of secretion by cell (GO:1903530) | 3.28 | 2 | KCNA5, GJA5 |
negative regulation of transporter activity (GO:0032410) | 5.59 | 2 | KCNQ1, KCNE2 |
anatomical structure morphogenesis (GO:0009653) | 2.53 | 2 | SCN5A, GJA5 |
regulation of protein localization (GO:0032880) | 2.88 | 2 | KCNA5, GJA5 |
response to endogenous stimulus (GO:0009719) | 2.79 | 2 | KCNQ1, NPPA |
negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 2 | NPPA, GJA5 |
response to oxygen levels (GO:0070482) | 4.02 | 2 | KCNA5, NPPA |
positive regulation of cell proliferation (GO:0008284) | 3.01 | 2 | SCN5A, KCNA5 |
cellular response to external stimulus (GO:0071496) | 4.2 | 2 | KCNJ2, NPPA |
negative regulation of delayed rectifier potassium channel activity (GO:1902260) | 7.53 | 2 | KCNQ1, KCNE2 |
cellular metal ion homeostasis (GO:0006875) | 3.75 | 2 | KCNJ2, KCNA5 |
cellular ion homeostasis (GO:0006873) | 3.57 | 2 | KCNJ2, KCNA5 |
cellular cation homeostasis (GO:0030003) | 3.6 | 2 | KCNJ2, KCNA5 |
cation homeostasis (GO:0055080) | 3.46 | 2 | KCNJ2, KCNA5 |
cellular chemical homeostasis (GO:0055082) | 3.4 | 2 | KCNJ2, KCNA5 |
AV node cell action potential (GO:0086016) | 8.34 | 2 | SCN5A, SCN4B |
nucleic acid metabolic process (GO:0090304) | 1.46 | 2 | NUP155, NPPA |
response to drug (GO:0042493) | 3.71 | 2 | KCNQ1, KCNE2 |
negative regulation of cation transmembrane transport (GO:1904063) | 5.65 | 2 | KCNQ1, KCNE2 |
macromolecule metabolic process (GO:0043170) | 0.83 | 2 | NUP155, NPPA |
positive regulation of cardiac muscle contraction (GO:0060452) | 7.24 | 2 | KCNQ1, NPPA |
response to nitrogen compound (GO:1901698) | 3.12 | 2 | KCNQ1, NPPA |
positive regulation of cation channel activity (GO:2001259) | 6.17 | 2 | NPPA, KCNE2 |
cellular homeostasis (GO:0019725) | 3.23 | 2 | KCNJ2, KCNA5 |
regulation of calcium ion transmembrane transport (GO:1903169) | 4.98 | 2 | NPPA, KCNE2 |
homeostatic process (GO:0042592) | 2.61 | 2 | KCNJ2, KCNA5 |
cellular response to drug (GO:0035690) | 5.48 | 2 | KCNQ1, KCNE2 |
regulation of blood pressure (GO:0008217) | 4.72 | 2 | NPPA, GJA5 |
AV node cell to bundle of His cell communication (GO:0086067) | 8.34 | 2 | SCN5A, GJA5 |
cell communication involved in cardiac conduction (GO:0086065) | 6.73 | 2 | SCN5A, GJA5 |
protein homooligomerization (GO:0051260) | 4.21 | 2 | KCNJ2, KCNA5 |
regulation of voltage-gated calcium channel activity (GO:1901385) | 6.59 | 2 | NPPA, KCNE2 |
response to pyrethroid (GO:0046684) | 8.12 | 2 | SCN2B, SCN1B |
negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.68 | 2 | KCNQ1, KCNE2 |
regulation of gene expression (GO:0010468) | 1.37 | 2 | NUP155, KCNQ1 |
positive regulation of muscle contraction (GO:0045933) | 5.9 | 2 | KCNQ1, NPPA |
organic substance biosynthetic process (GO:1901576) | 1.34 | 2 | NUP155, NPPA |
cellular protein localization (GO:0034613) | 3.11 | 2 | NUP155, SCN3B |
biosynthetic process (GO:0009058) | 1.32 | 2 | NUP155, NPPA |
multi-organism cellular process (GO:0044764) | 3.14 | 2 | ABCC9, NUP155 |
monovalent inorganic cation homeostasis (GO:0055067) | 4.93 | 2 | KCNJ2, KCNA5 |
metal ion homeostasis (GO:0055065) | 3.61 | 2 | KCNJ2, KCNA5 |
cell-cell signaling (GO:0007267) | 3.35 | 2 | SCN2B, SCN1B |
cellular localization (GO:0051641) | 2.32 | 2 | NUP155, SCN3B |
regulation of calcium ion transmembrane transporter activity (GO:1901019) | 5.49 | 2 | NPPA, KCNE2 |
nervous system development (GO:0007399) | 3.53 | 2 | SCN2B, SCN3B |
negative regulation of blood pressure (GO:0045776) | 5.99 | 2 | NPPA, GJA5 |
regulation of calcium ion transport (GO:0051924) | 4.38 | 2 | NPPA, KCNE2 |
negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.96 | 2 | KCNQ1, KCNE2 |
viral process (GO:0016032) | 3.15 | 2 | ABCC9, NUP155 |
symbiosis, encompassing mutualism through parasitism (GO:0044403) | 3.15 | 2 | ABCC9, NUP155 |
single-organism cellular localization (GO:1902580) | 3.16 | 2 | NUP155, SCN3B |